Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 39 of 39 entries
View as:

This is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly Population

Phase: N/A Priority: Normal
NCT ID: NCT01158599 Org: User:
Start: 06/30/10 End: 10/31/11 Due: 10/31/12

Virological Response Study of the HCV Vaccine IC41

Phase: N/A Priority: Normal
NCT ID: NCT00601770 Org: User:
Start: 02/28/06 End: 07/31/08 Due: 07/31/09

Study Assessing Immunogenicity and Safety of IC43 In Intensive Care Patients

Phase: N/A Priority: Normal
NCT ID: NCT00876252 Org: User:
Start: 12/31/08 End: 02/28/10 Due: 02/28/11

Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51

Phase: N/A Priority: Normal
NCT ID: NCT00595309 Org: User:
Start: 12/31/07 End: 10/31/09 Due: 10/31/10

Study Assessing Safety and Immunogenicity of IC43 Vaccination Against Pseudomonas Aeruginosa in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00778388 Org: User:
Start: 09/30/08 End: 09/30/09 Due: 09/30/10

Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine Candidate (VLA1601) in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06334393 Org: User:
Start: 03/25/24 End: 04/27/26 Due: 04/27/27

Confirmatory Phase II/III Study Assessing Efficacy, Immunogenicity and Safety of IC43

Phase: N/A Priority: Normal
NCT ID: NCT01563263 Org: User:
Start: 03/31/12 End: 12/31/15 Due: 12/31/16

A Phase 2 Clinical Trial of VLA1553 in Healthy Children Aged 1 to 11 Years

Phase: N/A Priority: Normal
NCT ID: NCT06106581 Org: User:
Start: 12/18/23 End: 07/31/25 Due: 07/31/26

Study Confirming A Human Challenge Model and Investigating The Safety Of VLA1701

Phase: N/A Priority: Normal
NCT ID: NCT03576183 Org: User:
Start: 06/04/18 End: 11/30/18 Due: 11/30/19

Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440

Phase: N/A Priority: Normal
NCT ID: NCT00596271 Org: User:
Start: 09/30/05 End: 08/31/08 Due: 08/31/09

Phase II Study of Immunization With a Hepatitis C Virus (HCV) Antigen Peptide Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00602784 Org: User:
Start: 11/30/02 End: 09/30/04 Due: 09/30/05

Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study

Phase: N/A Priority: Normal
NCT ID: NCT01246479 Org: User:
Start: 10/31/10 End: 09/30/14 Due: 09/30/15

Comparison of Three Commercial Batches of the Japanese Encephalitis Vaccine IC51

Phase: N/A Priority: Normal
NCT ID: NCT00595465 Org: User:
Start: 12/31/07 End: 06/30/08 Due: 06/30/09

Open-label, Randomized Study in a Pediatric Population in a JEV (Japanese Encephalitis Virus)-Endemic Country

Phase: N/A Priority: Normal
NCT ID: NCT01296360 Org: User:
Start: 12/31/10 End: 10/31/13 Due: 10/31/14